Controlled delivery of BID protein fused with TAT peptide sensitizes cancer cells to apoptosis

TBK1 Regulates Prostate Cancer Dormancy through mTOR Inhibition

(2015) Jin Koo Kim et al.   NEOPLASIA

WISP1/CCN4: A Potential Target for Inhibiting Prostate Cancer Growth and Spread to Bone

(2013) Mitsuaki Ono et al.   PLoS One

Evading apoptosis in cancer

(2013) Kaleigh Fernald et al.   TRENDS IN CELL BIOLOGY

TRAIL on trial: preclinical advances in cancer therapy

(2013) Daniel W. Stuckey et al.   TRENDS IN MOLECULAR MEDICINE

TRAIL Signaling and Synergy Mechanisms Used in TRAIL-Based Combination Therapies

(2012) C. T. Hellwig et al.   MOLECULAR CANCER THERAPEUTICS

Introduction of hypoxia-targeting p53 fusion protein for the selective therapy of non-small cell lung cancer

(2011) Yu Zhao et al.   CANCER BIOLOGY & THERAPY

BID is a Critical Factor Controlling Cell Viability Regulated by IFN-α

(2011) Takaya Tsuno et al.   JOURNAL OF IMMUNOTHERAPY

Expression Profile of Apoptosis Related Genes and Radio-sensitivity of Prostate Cancer Cells

(2011) Zhenhua HE et al.   JOURNAL OF RADIATION RESEARCH

Cell-Penetrating TAT-FOXO3 Fusion Proteins Induce Apoptotic Cell Death in Leukemic Cells

(2011) M. Essafi et al.   MOLECULAR CANCER THERAPEUTICS

Synergistic tumor growth-inhibitory effect of the prostate-specific antigen-activated fusion peptide BSD352 for prostate cancer therapy

(2010) Bin Li et al.   ANTI-CANCER DRUGS

Protein Kinase CK2 Is a Central Regulator of Topoisomerase I Hyperphosphorylation and Camptothecin Sensitivity in Cancer Cell Lines

(2010) Keya Bandyopadhyay et al.   BIOCHEMISTRY

Proapoptotic Bid mediates the Atr-directed DNA damage response to replicative stress

(2010) Y Liu et al.   CELL DEATH AND DIFFERENTIATION

Activity of protein kinase CK2 uncouples Bid cleavage from caspase-8 activation

(2010) C. T. Hellwig et al.   JOURNAL OF CELL SCIENCE

Phase I Dose-Escalation Study of Recombinant Human Apo2L/TRAIL, a Dual Proapoptotic Receptor Agonist, in Patients With Advanced Cancer

(2010) Roy S. Herbst et al.   JOURNAL OF CLINICAL ONCOLOGY

The Pharmacokinetics of Cell-Penetrating Peptides

(2010) Dikran Sarko et al.   MOLECULAR PHARMACEUTICS

The inhibition of Bid expression by Akt leads to resistance to TRAIL-induced apoptosis in ovarian cancer cells

(2010) N Goncharenko-Khaider et al.   ONCOGENE

Anti-Cancer Therapies that Utilize Cell Penetrating Peptides

(2010) Benjamin Bitler et al.   Recent Patents on Anti-Cancer Drug Discovery

Cytotoxicity, intracellular distribution and uptake of doxorubicin and doxorubicin coupled to cell-penetrating peptides in different cell lines: A comparative study

(2009) Sonia Aroui et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Bcl-2 Family Proteins Contribute to Apoptotic Resistance in Lung Cancer Multicellular Spheroids

(2008) Tsung-Ming Yang et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Bid exhibits S phase checkpoint activation and plays a pro-apoptotic role in response to etoposide-induced DNA damage in hepatocellular carcinoma cells

(2008) Gang Song et al.   APOPTOSIS

TRAIL receptor signalling and modulation: Are we on the right TRAIL?

(2008) Devalingam Mahalingam et al.   CANCER TREATMENT REVIEWS

Real Time Analysis of Tumor Necrosis Factor-related Apoptosis-inducing Ligand/Cycloheximide-induced Caspase Activities during Apoptosis Initiation

(2008) Christian T. Hellwig et al.   JOURNAL OF BIOLOGICAL CHEMISTRY